Pharmosa Biopharm Inc. (TPEX:6875)

Pharmosa Biopharm Statistics

Total Valuation

TPEX:6875 has a market cap or net worth of TWD 6.65 billion. The enterprise value is 5.46 billion.

Market Cap	6.65B
Enterprise Value	5.46B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6875 has 129.09 million shares outstanding. The number of shares has increased by 7.75% in one year.

Current Share Class	129.09M
Shares Outstanding	129.09M
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.77%
Owned by Institutions (%)	2.19%
Float	76.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.29
PB Ratio	3.88
P/TBV Ratio	3.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.37
EV / Sales	31.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.60

Financial Position

The company has a current ratio of 14.27, with a Debt / Equity ratio of 0.06.

Current Ratio	14.27
Quick Ratio	13.49
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.25
Interest Coverage	-121.54

Financial Efficiency

Return on equity (ROE) is -15.23% and return on invested capital (ROIC) is -8.86%.

Return on Equity (ROE)	-15.23%
Return on Assets (ROA)	-8.45%
Return on Invested Capital (ROIC)	-8.86%
Return on Capital Employed (ROCE)	-15.40%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.08
Inventory Turnover	1.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.59% in the last 52 weeks. The beta is 0.42, so TPEX:6875's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-14.59%
50-Day Moving Average	49.40
200-Day Moving Average	48.45
Relative Strength Index (RSI)	47.99
Average Volume (20 Days)	376,031

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6875 had revenue of TWD 173.63 million and -281.94 million in losses. Loss per share was -2.19.

Revenue	173.63M
Gross Profit	126.95M
Operating Income	-279.06M
Pretax Income	-281.94M
Net Income	-281.94M
EBITDA	-260.65M
EBIT	-279.06M
Loss Per Share	-2.19

Balance Sheet

The company has 1.30 billion in cash and 108.68 million in debt, giving a net cash position of 1.19 billion or 9.19 per share.

Cash & Cash Equivalents	1.30B
Total Debt	108.68M
Net Cash	1.19B
Net Cash Per Share	9.19
Equity (Book Value)	1.71B
Book Value Per Share	13.26
Working Capital	1.28B

Cash Flow

In the last 12 months, operating cash flow was -256.50 million and capital expenditures -176.86 million, giving a free cash flow of -433.37 million.

Operating Cash Flow	-256.50M
Capital Expenditures	-176.86M
Free Cash Flow	-433.37M
FCF Per Share	-3.36

Margins

Gross margin is 73.11%, with operating and profit margins of -160.72% and -162.38%.

Gross Margin	73.11%
Operating Margin	-160.72%
Pretax Margin	-162.38%
Profit Margin	-162.38%
EBITDA Margin	-150.12%
EBIT Margin	-160.72%
FCF Margin	n/a

Dividends & Yields

TPEX:6875 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	-4.24%
FCF Yield	-6.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6875 has an Altman Z-Score of 22.21 and a Piotroski F-Score of 1.

Altman Z-Score	22.21
Piotroski F-Score	1